Increase/Decrease in Cash: The total change in cash for the company over the given period.
Cocrystal Pharma, Inc. (COCP) had Increase/Decrease in Cash of $-10.79M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-17.98M |
|
-- |
|
-- |
|
$18.56M |
|
$-18.56M |
|
$0.57M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
$-18.56M |
|
$-19.95M |
|
9.65M |
|
9.65M |
|
$-1.87 |
|
$-1.87 |
|
| Balance Sheet Financials | |
$29.09M |
|
$0.27M |
|
$2.17M |
|
$31.26M |
|
$3.26M |
|
-- |
|
$1.61M |
|
$4.88M |
|
$26.38M |
|
$26.38M |
|
$26.38M |
|
10.17M |
|
| Cash Flow Statement Financials | |
$-14.67M |
|
$-0.12M |
|
$3.99M |
|
$37.22M |
|
$26.43M |
|
|
Increase/Decrease in Cash |
$-10.79M |
$0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.16% |
|
-68.16% |
|
-57.53% |
|
-68.16% |
|
$2.59 |
|
$-1.53 |
|
$-1.52 |
|